| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,311 |
1,081 |
$177K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
357 |
287 |
$94K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
831 |
674 |
$53K |
| 87641 |
|
1,314 |
1,036 |
$20K |
| 87581 |
|
1,195 |
966 |
$18K |
| 87498 |
|
1,172 |
944 |
$18K |
| 87541 |
|
1,172 |
944 |
$18K |
| 87486 |
|
1,172 |
944 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,025 |
813 |
$12K |
| 87561 |
|
357 |
287 |
$9K |
| 87481 |
|
152 |
128 |
$8K |
| 87640 |
|
1,109 |
886 |
$6K |
| 87653 |
|
155 |
129 |
$3K |
| 87500 |
|
127 |
111 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$323.26 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16 |
16 |
$221.06 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
16 |
$221.06 |
| 87511 |
|
13 |
13 |
$189.48 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
14 |
$189.48 |
| 87529 |
|
16 |
16 |
$63.16 |